Johnson & Johnson vs Solaris Energy Infrastructure Inc. Class A Common Stock — how do they compare? Johnson & Johnson trades at $259.21 (market cap $599.12B), while Solaris Energy Infrastructure Inc. Class A Common Stock trades at $67.34 (market cap $5.12B). The key difference: Johnson & Johnson is far larger — about 117× Solaris Energy Infrastructure Inc. Class A Common Stock's market cap, and Johnson & Johnson pays the higher dividend (2.16%). Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and Solaris Energy Infrastructure Inc. Class A Common Stock for 0 Days on average.
| JNJ | SEI | |
|---|---|---|
Market Cap | $599.12B | $5.12B |
Volume | 16,640,951 | 2,532,496 |
Sector | Health | Energy |
52-Week High | $278.43 | $82.88 |
52-Week Low | $186.00 | $40.64 |
Typical Hold Time | 129 Days | 0 Days |
Enterprise Value | $627.40B | $6.81B |
Dividend Yield | 2.16% | 0.62% |
Signals from Pluang's Aura AI — not financial advice
JNJ trades at $253.91, down 3.72% on the day, amid a mixed technical and fundamental backdrop. The stock shows strong profitability with a 21.48% net income margin and 25.74% ROE, supported by three consecutive quarterly EPS beats. Analyst consensus is bullish with a $282.73 price target, though recent news highlights competitive pressures and patent cliff concerns. Cash flow trends indicate robust operations but elevated investing outflows.
The outlook remains positive given JNJ's diversified healthcare portfolio and innovation pipeline, but investors face risks from debt levels rising to 24.06% of assets and biosimilar competition. Near-term resistance lies at $265, with support at $257. Institutional sentiment favors growth in pharmaceuticals and medical technology, though macroeconomic and regulatory headwinds persist.
SEI (Solaris Energy Infrastructure) trades at $77.83, down 1.83% today, but maintains strong analyst support with 9 unanimous buy ratings and a $100.56 consensus price target. The stock shows positive momentum with three consecutive quarterly earnings beats and projected revenue growth from $622M in 2025 to $762M in 2026. Recent technical analysis indicates neutral signals with support at $76 and resistance at $79.
The outlook remains positive given strong earnings performance and expansion initiatives, though elevated valuation ratios (P/E of 98.52) and significant debt issuance ($1.25B notes) present risks. The upcoming Q3 2026 earnings report on October 21 will be crucial for validating growth trajectory amid energy sector volatility.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →Solaris Energy Infrastructure, Inc. provides mobile power generation, control, and distribution equipment and logistics equipment for managing raw materials at well sites, operating through its Solaris Power Solutions and Solaris Logistics Solutions segments for data center, energy, commercial, and industrial customers.
Read more on SEI →